These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 2894701

  • 21. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P, Garzón J.
    Eur J Pharmacol; 1989 Jan 02; 159(1):9-23. PubMed ID: 2565240
    [Abstract] [Full Text] [Related]

  • 22. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC, Robles L, Mosberg HI.
    J Pharmacol Exp Ther; 1987 Feb 02; 240(2):571-7. PubMed ID: 3027318
    [Abstract] [Full Text] [Related]

  • 23. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S, Kim HS, Wood PL.
    Brain Res; 1987 Dec 01; 435(1-2):220-6. PubMed ID: 2892574
    [Abstract] [Full Text] [Related]

  • 24. Hyperthermic response of the cat to intraventricular injection of the opioid delta-receptor agonist D-Ala2-D-Leu5-enkephalin.
    Pang IH, Bernardini GL, Clark WG.
    Brain Res Bull; 1984 Aug 01; 13(2):263-8. PubMed ID: 6093942
    [Abstract] [Full Text] [Related]

  • 25. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A, Feuerstein G, Kopin IJ, Faden AI.
    J Pharmacol Exp Ther; 1983 Jun 01; 225(3):735-41. PubMed ID: 6306217
    [Abstract] [Full Text] [Related]

  • 26. Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat.
    Feuerstein G, Faden AI.
    Life Sci; 1983 Jun 01; 31(20-21):2197-200. PubMed ID: 6131355
    [Abstract] [Full Text] [Related]

  • 27. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
    Tavani A, Petrillo P, La Regina A, Sbacchi M.
    J Pharmacol Exp Ther; 1990 Jul 01; 254(1):91-7. PubMed ID: 2164103
    [Abstract] [Full Text] [Related]

  • 28. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA, Burks TF.
    J Pharmacol Exp Ther; 1988 Feb 01; 244(2):456-62. PubMed ID: 2831341
    [Abstract] [Full Text] [Related]

  • 29. Opioid receptors and prejunctional modulation of capsaicin-sensitive sensory nerves in guinea-pig left atrium.
    Giuliani S, Maggi CA, Meli A.
    Gen Pharmacol; 1990 Feb 01; 21(4):417-21. PubMed ID: 1974221
    [Abstract] [Full Text] [Related]

  • 30. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
    Dray A, Metsch R.
    Eur J Pharmacol; 1984 Sep 03; 104(1-2):47-53. PubMed ID: 6094211
    [Abstract] [Full Text] [Related]

  • 31. Regional interactions of opioid peptides at mu and delta sites in rat brain.
    Hewlett WA, Barchas JD.
    Peptides; 1983 Sep 03; 4(6):853-8. PubMed ID: 6324140
    [Abstract] [Full Text] [Related]

  • 32. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ, Roerig SC, Fujimoto JM.
    J Pharmacol Exp Ther; 1991 Feb 03; 256(2):448-57. PubMed ID: 1847196
    [Abstract] [Full Text] [Related]

  • 33. Central opioid modulation of fetal cardiovascular function: role of mu- and delta-receptors.
    Szeto HH, Zhu YS, Cai LQ.
    Am J Physiol; 1990 Jun 03; 258(6 Pt 2):R1453-8. PubMed ID: 2163223
    [Abstract] [Full Text] [Related]

  • 34. Effects of dynorphin A (1-17), dynorphin A (1-13) and D-ala2-D-leu5-enkephalin on the excitability of pyramidal cells in CA1 and CA2 of the rat hippocampus in vitro.
    Vidal C, Maier R, Zieglgänsberger W.
    Neuropeptides; 1984 Dec 03; 5(1-3):237-40. PubMed ID: 6152322
    [Abstract] [Full Text] [Related]

  • 35. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS, Mulvaney SA, Mosberg HI, Porreca F.
    Brain Res; 1987 Sep 08; 420(1):100-8. PubMed ID: 2823970
    [Abstract] [Full Text] [Related]

  • 36. Tolerance and cross tolerance to morphine after chronic spinal D-Ala2-D-Leu5-enkephalin infusion.
    Tseng LF.
    Life Sci; 1982 Sep 06; 31(10):987-92. PubMed ID: 6752616
    [Abstract] [Full Text] [Related]

  • 37. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D, Bodnar RJ, Gistrak MA, Pasternak GW.
    Eur J Pharmacol; 1989 Sep 22; 168(3):307-14. PubMed ID: 2555205
    [Abstract] [Full Text] [Related]

  • 38. Beta-endorphin-(1-27) antagonizes beta-endorphin- but not morphine-, D-Pen2-D-Pen5-enkephalin- and U50, 488H-induced analgesia in mice.
    Suh HH, Tseng LF, Li CH.
    Neuropharmacology; 1988 Sep 22; 27(9):957-63. PubMed ID: 2972939
    [Abstract] [Full Text] [Related]

  • 39. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
    Vaught JL, Rothman RB, Westfall TC.
    Life Sci; 1982 Apr 26; 30(17):1443-55. PubMed ID: 6283293
    [Abstract] [Full Text] [Related]

  • 40. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa).
    Spain JW, Roth BL, Coscia CJ.
    J Neurosci; 1985 Mar 26; 5(3):584-8. PubMed ID: 2983043
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.